Literature DB >> 9770440

A role for the beta-amyloid precursor protein in memory?

S S Sisodia1, M Gallagher.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9770440      PMCID: PMC33903          DOI: 10.1073/pnas.95.21.12074

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  45 in total

1.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

Authors:  S S Sisodia; E H Koo; K Beyreuther; A Unterbeck; D L Price
Journal:  Science       Date:  1990-04-27       Impact factor: 47.728

Review 2.  Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities.

Authors:  S Gandy; P Greengard
Journal:  Trends Pharmacol Sci       Date:  1992-03       Impact factor: 14.819

3.  Cleavage of amyloid beta peptide during constitutive processing of its precursor.

Authors:  F S Esch; P S Keim; E C Beattie; R W Blacher; A R Culwell; T Oltersdorf; D McClure; P J Ward
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

Authors:  E A Milward; R Papadopoulos; S J Fuller; R D Moir; D Small; K Beyreuther; C L Masters
Journal:  Neuron       Date:  1992-07       Impact factor: 17.173

5.  Beta-amyloid precursor protein cleavage by a membrane-bound protease.

Authors:  S S Sisodia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

6.  Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

Authors:  C Haass; E H Koo; A Mellon; A Y Hung; D J Selkoe
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

7.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Authors:  J D Buxbaum; M Oishi; H I Chen; R Pinkas-Kramarski; E A Jaffe; S E Gandy; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage.

Authors:  A Y Hung; E H Koo; C Haass; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.

Authors:  W Wasco; K Bupp; M Magendantz; J F Gusella; R E Tanzi; F Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

Authors:  R M Nitsch; B E Slack; R J Wurtman; J H Growdon
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

View more
  6 in total

1.  Solution studies and structural model of the extracellular domain of the human amyloid precursor protein.

Authors:  Matthias Gralle; Michelle M Botelho; Cristiano L P de Oliveira; Iris Torriani; Sérgio T Ferreira
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

2.  G protein-coupled receptors as disease targets: emerging paradigms.

Authors:  Julia L Cook
Journal:  Ochsner J       Date:  2010

Review 3.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Authors:  David A Hicks; Natalia N Nalivaeva; Anthony J Turner
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

5.  What does complement do in Alzheimer's disease? Old molecules with new insights.

Authors:  Yong Shen; Libang Yang; Rena Li
Journal:  Transl Neurodegener       Date:  2013-10-12       Impact factor: 8.014

Review 6.  Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma.

Authors:  Alexandre Vallée; Yves Lecarpentier
Journal:  Front Neurosci       Date:  2016-10-19       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.